NFKB1 and dry eye syndrome: ,7 Treatment with an NF-kB inhibitor was found to prevent disruption of immune tolerance in the desiccating stress (DS) dry eye model, suggesting that NF-kB activation could be an initiating event in the dry eye inflammatory cascade.6